These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2970176

  • 1. [Clinical relevance of the determination of plasma atrial natriuretic peptide in children with chronic renal failure].
    Rascher W, Bald M, Kröner F, Tulassay T, Müller-Wiefel DE.
    Z Kardiol; 1988; 77 Suppl 2():61-4. PubMed ID: 2970176
    [Abstract] [Full Text] [Related]

  • 2. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis.
    Bald M, Bonzel KE, Rascher W.
    Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967
    [Abstract] [Full Text] [Related]

  • 3. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
    Plum J, Ziyaie M, Kemmer FW, Passlick-Deetjen J, Grabensee B.
    Adv Perit Dial; 1990 Jul; 6():211-9. PubMed ID: 1982811
    [Abstract] [Full Text] [Related]

  • 4. Atrial natriuretic peptide (ANP) is removed by peritoneal dialysis in humans.
    Fincher ME, Campbell HT, Sklar AH, Caruana RJ, Lightfoot BO, Cheek PL, Smith KL, Hess CP.
    Adv Perit Dial; 1989 Jul; 5():16-9. PubMed ID: 2577402
    [Abstract] [Full Text] [Related]

  • 5. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure.
    Eisenhauer T, Talartschik J, Scheler F.
    Klin Wochenschr; 1986 Jul; 64 Suppl 6():68-72. PubMed ID: 2948067
    [Abstract] [Full Text] [Related]

  • 6. [Is the plasma ANP level an index of volume expansion in dialysis patients?].
    Talartschik J, Eisenhauer T, Voth E, Sold G, Scheler F.
    Z Kardiol; 1988 Jul; 77 Suppl 2():72-7. PubMed ID: 2970178
    [Abstract] [Full Text] [Related]

  • 7. [Levels of immunoreactive atrial natriuretic peptide in the blood of children on hemodialysis therapy].
    Jovanović O, Mirić-Nastić D, Popović-Rolović M, Antić-Peco A, Kostić M, Kruscić D.
    Srp Arh Celok Lek; 1992 Jul; 120(9-10):277-80. PubMed ID: 1306019
    [Abstract] [Full Text] [Related]

  • 8. Increased plasma levels of atrial natriuretic peptide in patients with chronic renal failure: effect of noradrenaline infusion.
    Jespersen B, Pedersen EB.
    Nephrol Dial Transplant; 1988 Jul; 3(6):762-7. PubMed ID: 2976128
    [Abstract] [Full Text] [Related]

  • 9. Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis.
    Korzets Z, Pomeranz M, Shilo L, Pomeranze A, Levi A, Shenkman L, Berheim J.
    Adv Perit Dial; 1989 Jul; 5():20-3. PubMed ID: 2577411
    [Abstract] [Full Text] [Related]

  • 10. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
    Pedersen EB, Bacevicius E, Bech JN, Solling K, Pedersen HB.
    Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
    [Abstract] [Full Text] [Related]

  • 11. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
    Kohse KP, Feifel K, Mayer-Wehrstein R.
    Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
    [Abstract] [Full Text] [Related]

  • 12. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F.
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [Abstract] [Full Text] [Related]

  • 13. Plasma cGMP level as a marker of the hydration state in renal replacement therapy.
    Lauster F, Heim JM, Drummer C, Fülle HJ, Gerzer R, Schiffl H.
    Kidney Int Suppl; 1993 Jun; 41():S57-9. PubMed ID: 8391608
    [Abstract] [Full Text] [Related]

  • 14. Central blood volume, atrial natriuretic peptide and intermittent hemodialysis.
    Wallin CJ, Rossi P, Jacobson SH, Leksell LG.
    Scand J Urol Nephrol; 2004 Jun; 38(1):78-84. PubMed ID: 15204432
    [Abstract] [Full Text] [Related]

  • 15. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
    Takahashi M, Nagake Y, Ichikawa H, Kawabata K, Nakazono H, Hirata K, Ogura T, Makino H.
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of atrial natriuretic peptide (ANP) in volume expanded patients: response to fluid removal by continuous pump driven hemofiltration.
    Hartter E, Pacher R, Frass M, Woloszczuk W, Leithner C.
    Klin Wochenschr; 1986 Apr; 64 Suppl 6():112-4. PubMed ID: 2948057
    [Abstract] [Full Text] [Related]

  • 17. Influence of hemodialysis on the plasma levels of the atrial natriuretic factor in chronic renal failure.
    Larochelle P, Béroniade V, Gutkowska J, Cusson JR, Lécrivain A, du Souich P, Cantin M, Genest J.
    Clin Invest Med; 1987 Jul; 10(4):350-4. PubMed ID: 2958203
    [Abstract] [Full Text] [Related]

  • 18. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF, Ingrosso D, Molino D, Galletti P, Montini G, Zacchello G, Bellantuono R, Caringella A, Fede C, Chimenz R, De Santo NG.
    J Nephrol; 2003 Jul; 16(4):516-21. PubMed ID: 14696753
    [Abstract] [Full Text] [Related]

  • 19. Circulating and excreted forms of atrial natriuretic peptide in healthy subjects and patients with renal diseases.
    Marumo F, Shichiri M, Emori T, Ando K.
    Clin Nephrol; 1992 Oct; 38(4):203-8. PubMed ID: 1424307
    [Abstract] [Full Text] [Related]

  • 20. Radioimmunoassay of atrial natriuretic peptide in human plasma: application to studies of volume and blood pressure homeostasis.
    Horký K, Srámková J, Tesar V, Lachmanová J, Widimský J.
    Physiol Bohemoslov; 1988 Oct; 37(4):299-305. PubMed ID: 2973615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.